Skip to main content

Insulin Aspart Injection Shortage

Last Updated: June 30, 2024
Status: Current

Reason for the Shortage
    • Novo Nordisk has their insulin aspart products available. The company did not provide availability information on Relion products.
Available Products
    • Fiasp subcutaneous injection, Novo Nordisk, 100 units/mL, 10 mL multiple dose vial, 1 count, NDC 00169-3201-11
    • Fiasp Flextouch subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 00169-3204-15
    • Fiasp Penfill subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 00169-3205-15
    • Insulin Aspart Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 73070-0103-15
    • Insulin Aspart Penfill subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 73070-0102-15
    • Novolog subcutaneous injection, Novo Nordisk, 100 units/mL, 10 mL multiple dose vial, 1 count, NDC 00169-7501-11
    • Novolog Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 00169-6339-10
    • Novolog Penfill subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 00169-3303-12
    • Insulin Aspart subcutaneous injection, Novo Nordisk, 100 units/mL, 10 mL multiple dose vial, 1 count, NDC 73070-0100-11

Updated

Updated June 30, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created November 10, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer